0001628280-26-032286 | 10-Q | XBRL Viewer

Print Document

Related Parties (Details) - USD ($)					3 Months Ended		8 Months Ended
Related Parties (Details) - USD ($)	Feb. 13, 2026	Nov. 14, 2025	Aug. 15, 2025	Jun. 18, 2025	Mar. 31, 2026	Mar. 31, 2025	Feb. 13, 2026	Dec. 31, 2025	May 31, 2025
Related Party Transaction [Line Items]
Operating lease right-of-use assets, net					$ 2,017,000			$ 3,114,000
Nangate Parties Cross-Complaint
Related Party Transaction [Line Items]
Settlement payment	$ 8,300,000	$ 4,100,000	$ 4,100,000				$ 32,500,000
Settlement payable (in percent)									75.00%
Nangate Parties Cross-Complaint \| Silvaco Group, Inc. And Co-Defendants
Related Party Transaction [Line Items]
Settlement payment				$ 16,000,000.0
Nangate Parties Cross-Complaint \| Co-Defendants
Related Party Transaction [Line Items]
Settlement payable (in percent)									25.00%
Kipee International, Inc \| Related Party
Related Party Transaction [Line Items]
Rent expense					100,000	$ 100,000
Operating lease liability					500,000
Operating lease right-of-use assets, net					500,000
New Horizons (Cambridge) LTD (“NHC”) and New Horizons France (“NHF”) \| Related Party
Related Party Transaction [Line Items]
Rent expense					100,000	$ 100,000
Operating lease liability					5,000.0
Operating lease right-of-use assets, net					5,000.0
New Horizons (Cambridge) LTD (“NHC”) \| Related Party
Related Party Transaction [Line Items]
Operating lease liability					700,000
Operating lease right-of-use assets, net					$ 700,000

Summary of Significant Accounting and Reporting Policies

3 Months Ended

Mar. 31, 2026

Accounting Policies [Abstract]

Summary of Significant Accounting and Reporting Policies

Basis of presentation and consolidation

The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles ("GAAP") and include the accounts of Silvaco and all of the Company's wholly owned subsidiaries with operations in North America, Europe, Asia, Africa, and South America. All intercompany transactions and balances have been eliminated upon consolidation.

The condensed consolidated financial statements as of March 31, 2026, and for the three months ended March 31, 2026, and 2025 are unaudited. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP have been omitted from these condensed consolidated financial statements, as permitted by Securities and Exchange Commission (“SEC”) rules and regulations. Accordingly, these condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2025, and the related notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on March 12, 2026. The condensed consolidated balance sheet as of December 31, 2025, was derived from the audited consolidated financial statements as of that date. In management’s opinion, the condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the condensed consolidated financial statements.

The results of operations for the three months ended March 31, 2026, are not necessarily indicative of the Company’s operating results to be expected for the full fiscal year or any other future interim or annual period.

Emerging growth company status

The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that the Company (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act.

Use of estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Estimates also affect the amounts of revenue and expenses during the reported periods. The Company’s most significant estimates relate to revenue recognition and the valuation of goodwill and other intangible assets. Other estimates include, but are not limited to, current expected credit losses for accounts receivable and contract assets, stock-based compensation expense, contingent consideration, uncertain tax positions, legal contingencies and income taxes. Actual results could differ from those estimates.

Concentrations of credit risk

Accounts receivable from customers representing 10% or more of the Company’s total accounts receivable were as follows:


	March 31,	December 31,
	2026	2025
Customer A	24%	—
Customer B	13%	11%
Customer C	10%	—
Customer D	—	14%
Customer E	—	10%

* Customer accounted for less than 10% of total accounts receivable at period end.

Revenue from customers representing 10% or more of the Company’s total revenue was as follows:


	Three Months Ended March 31,
	2026	2025
Customer B	10%	—
Customer F	—	12%

* Customer accounted for less than 10% of total revenue during the period.

In addition to the concentration of credit risk with respect to trade receivables and revenue, the Company's cash on deposit with financial institutions is also exposed to concentration risk. The Company's cash on deposit with financial institutions is insured through various public and private bank deposit insurance programs, foreign and domestic; however, a significant portion of cash balances held as of March 31, 2026, and December 31, 2025, exceeded insured limits.

As of March 31, 2026, $3.0 million, or 28%, of the Company’s cash and cash equivalents was maintained with one financial institution, where the Company’s current deposits are in excess of federally insured limits, and $4.7 million, or 43%, was held by the Company’s foreign subsidiaries.

Accumulated other comprehensive loss

Accumulated other comprehensive loss is composed of foreign currency translation adjustments and unrealized gains and losses on marketable securities.

Foreign currencies

The financial statements of Silvaco's international subsidiaries with local functional currencies are translated to U.S. dollars upon consolidation. Assets and liabilities are translated at the effective exchange rate on the balance sheet date. Results of operations are translated at average exchange rates, which approximate rates in effect when the underlying transactions occur. The Company recorded foreign currency translation adjustments of $0.3 million for the three months ended March 31, 2026, and 2025, respectively, within accumulated other comprehensive loss.

Certain of the Company’s sales and intercompany transactions are denominated in foreign currencies. These transactions are recorded in functional currency at the appropriate exchange rate on the transaction date. Monetary assets and liabilities denominated in a currency other than the Company's functional currency or its subsidiaries' functional currencies are remeasured at the effective exchange rate on the balance sheet date. Gains and losses resulting from foreign exchange transactions are included in Interest and other expense, net in the Company’s condensed consolidated statements of operations. The Company recorded net foreign exchange transaction losses of $0.2 million for each of the three months ended March 31, 2026, and 2025.

Net loss per share

Basic net loss per share is computed based on the weighted average number of shares of common stock outstanding. Because the Company was in a loss position for all periods presented, the diluted earnings per share are equal to the basic earnings per share as the effect of potentially dilutive securities would have been antidilutive.

The following outstanding securities were excluded from the computation of diluted net loss per share because the effect would be anti-dilutive.


	March 31,
	2026	2025
Restricted Stock Unit (“RSU”) Grants	4,207,079	1,474,294
Employee Stock Purchase Plan	153,099	—
Contingently issuable shares to the CEO	14,124	—

Recently adopted accounting standards

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. This ASU provides a practical expedient that allows entities to estimate expected credit losses for current accounts receivable and contract assets assuming that conditions at the balance sheet date remain unchanged over the life of the asset. This ASU is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years. The Company adopted this ASU on January 1, 2026, prospectively and the impact was not material to the condensed consolidated financial statements.

Accounting guidance issued and not yet adopted

In November 2024, the FASB issued ASU No. 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses. This ASU requires additional disclosure of certain amounts included in the expense captions presented on the statements of operations as well as disclosures about selling expenses. This ASU is effective on a prospective basis, with the option for retrospective application, for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this accounting standard update on its condensed consolidated financial statements and related disclosures.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. This ASU eliminates the accounting consideration of software project development stages to align with the agile method for developing software and enhances the guidance related to assessing the probability of project completion. This ASU is effective for annual periods beginning after December 15, 2027, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on the condensed consolidated financial statements.

Description of Business	3 Months Ended
Description of Business	Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business Silvaco Group, Inc. (“Silvaco,” and the “Company” refers to Silvaco Group Inc. and its subsidiaries, unless the context specifically requires otherwise) was incorporated as a Delaware corporation on November 18, 2009. The Company is a provider of technology computer aided design (“TCAD”) software, electronic data automation (“EDA”) software and semiconductor intellectual property (“SIP”). TCAD, EDA and SIP solutions enable semiconductor companies to increase productivity, accelerate their products’ time-to-market and reduce their development and manufacturing costs. The Company’s TCAD solutions are used in the semiconductor industry to model and optimize manufacturing processes and device performance. The Company’s EDA software is used by semiconductor companies to design, simulate, and verify semiconductors. The Company’s SIP portfolio includes a range of products, including foundation technology, such as standard cells and memory compilers, as well as a suite of interface technologies. The Company’s customers include semiconductor manufacturers and systems companies that design and manufacture products containing semiconductors. Semiconductors are at the heart of innovation in many industries, including AI, display, power devices, automotive, memory, hyperscale and cloud computing, internet of things, telecommunications and many more.

Debt and Financing Obligations - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended
	Apr. 11, 2024	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Debt Instrument [Line Items]
Present value of vendor financing obligation		$ 3,275		$ 3,200
Vendor financing obligation, interest rate (in percent)		9.00%
Vendor financing obligation, interest expense		$ 100	$ 100
Licensed IP
Debt Instrument [Line Items]
License agreement, cash consideration	$ 6,000
License agreement, term extension (in years)	5 years

Related Parties	3 Months Ended
Related Parties	Mar. 31, 2026
Related Party Transactions [Abstract]
Related Parties	Related Parties The Company has a commercial lease agreement with Kipee International, Inc., a related party controlled by a principal stockholder and member of the Company’s board of directors, for Silvaco's corporate office in Santa Clara, California. In connection with this lease arrangement, which expires on April 30, 2028, the Company recorded rent expense of $0.1 million in each of the three months ended March 31, 2026, and 2025. The Company's right-of-use asset and operating lease liability for this property is $0.5 million as of March 31, 2026. The Company has international office leases with New Horizons (Cambridge) LTD (“NHC”) and New Horizons France (“NHF”) in Cambridgeshire, England and Grenoble, France, respectively. NHC and NHF are real estate entities owned and controlled by a principal stockholder and member of the Company’s board of directors. In connection with these lease arrangements, the Company recorded rent expense of $0.1 million in each of the three months ended March 31, 2026, and 2025. The Company's right-of-use asset and operating lease liability under the NHF lease, which expires on April 30, 2026, is $5.0 thousand as of March 31, 2026. During the three months ended March 31, 2026, the Company terminated its existing lease with NHC and executed a new office lease with NHC. Accordingly, the Company de-recognized the right-of-use asset and operating lease liability of $0.7 million at the time of termination. Under the new NHC lease, the Company did not record a right-of-use asset and lease liability as the lease is a short-term lease. In May 2025, the Company and two of our principal stockholders and members of our board of directors (the “Co-Defendants”) agreed to a Settlement Agreement in connection with a trial court judgment awarded to the Nangate Parties. The $32.5 million settlement (the “Settlement Payment”) consists of $16.0 million payable on June 18, 2025, $4.1 million payable on August 15, 2025, $4.1 million payable on November 14, 2025, and final payment of $8.3 million payable on February 13, 2026. Following the execution of the Settlement Agreement, the Co-Defendants, each a principal stockholder of the Company and a member of the Company’s board of directors, executed an apportionment agreement with the Company under which the Co-Defendants agreed to bear 25% of the Settlement Payment, with the Company bearing the remaining 75%. During the three months ended March 31, 2026, the Company made the final payment of $8.3 million and as of March 31, 2026, there is no remaining liability under the Settlement Agreement. Refer to Note 13, Commitments and Contingencies, for additional information.

Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 29,709	$ 30,529
Accumulated Amortization	(4,799)	(4,502)
Total net carrying value of intangible assets	$ 24,910	$ 26,027
Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	7 years	7 years
Gross Carrying Value	$ 4,980	$ 5,780
Accumulated Amortization	(580)	(1,199)
Total net carrying value of intangible assets	$ 4,400	$ 4,581
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	7 years	7 years
Gross Carrying Value	$ 14,120	$ 14,120
Accumulated Amortization	(1,863)	(1,307)
Total net carrying value of intangible assets	$ 12,257	$ 12,813
Trade name
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	12 years	12 years
Gross Carrying Value	$ 5,630	$ 5,630
Accumulated Amortization	(365)	(234)
Total net carrying value of intangible assets	$ 5,265	$ 5,396
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)		5 years
Gross Carrying Value		$ 20
Accumulated Amortization		(20)
Total net carrying value of intangible assets		$ 0
Licensed IP
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	5 years	5 years
Gross Carrying Value	$ 4,979	$ 4,979
Accumulated Amortization	(1,991)	(1,742)
Total net carrying value of intangible assets	$ 2,988	$ 3,237

Restructuring - Narrative (Details) $ in Thousands	3 Months Ended	12 Months Ended
Restructuring - Narrative (Details) $ in Thousands	Mar. 31, 2026 USD ($) position	Dec. 31, 2025 USD ($)
Restructuring Cost and Reserve [Line Items]
Number of terminated employees \| position	68
Incurred restructuring cost	$ 1,500	$ 1,300
Remaining obligations	600	$ 102
2025 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring cost	$ 5,000

Revenue (Details) $ in Millions	3 Months Ended
Revenue (Details) $ in Millions	Mar. 31, 2026 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 46.6
Contract with customer, liability, revenue recognized	$ 4.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation (in percent)	52.00%
Revenue, remaining performance obligation, expected timing of satisfaction, period	12 months

Revenue	3 Months Ended
Revenue	Mar. 31, 2026
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company's revenue is derived principally from software licensing, customization and related maintenance and services, which are generally accounted for as separate performance obligations with differing revenue recognition patterns. Arrangements with both software licenses and customization services are accounted for as a combined performance obligation. The transaction price is allocated to each distinct performance obligation based on the relative standalone selling price. Revenue from software licenses is classified as software license revenue. Software license revenue is recognized upfront upon delivery of the licensed software. Revenue associated with the license of the Company’s SIP is classified as software license revenue and recognized as revenue (i) upfront upon delivery of the standard SIP license, or (ii) over time when customization services are combined with the SIP license, as specific contractual milestones are met and incremental functionality is delivered to the customer. Maintenance and service revenue, which consists of both PCS for software licenses and support services for SIP licenses, is recognized ratably over the term of the contract period. Professional services revenue, which is classified as maintenance and service revenue, is recognized based on when the Company delivers the related service pursuant to the terms of the arrangement. Customer contracts The Company accounts for a contract with a customer when both parties have approved the contract and are committed to perform their respective obligations, each party’s rights and payment terms can be identified, the contract has commercial substance, and it is probable the Company will collect substantially all of the consideration it is entitled to. For multi-year software licenses, the Company generally invoices customers annually at the beginning of each annual coverage period. Transaction price allocated to the remaining performance obligations As of March 31, 2026, approximately $46.6 million of revenue is expected to be recognized from remaining performance obligations. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes both deferred revenue and backlog. The Company's backlog represents installment billings for periods beyond the current billing cycle. The Company expects to recognize revenue on approximately 52% of these remaining performance obligations over the next 12 months, with the remaining balance recognized thereafter. Deferred revenue Deferred revenue is comprised mainly of unearned revenue related to PCS on software licenses and pending software license and SIP license deliveries. Deferred revenue also includes contracts for professional services to be performed in the future. During the three months ended March 31, 2026, the Company recognized revenue of $4.1 million that was included in the total deferred revenue balance as of December 31, 2025. All other activity in deferred revenue is due to the timing of invoices in relation to the timing of revenue recognized during the three months ended March 31, 2026, as described above.

Restructuring - Schedule of Restructuring Reserve (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2026 USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 102
Charges	1,470
Cash payments	(648)
Non-cash payments	(324)
Ending balance	600
Employee Compensation
Restructuring Reserve [Roll Forward]
Beginning balance	33
Charges	1,470
Cash payments	(587)
Non-cash payments	(324)
Ending balance	592
Other
Restructuring Reserve [Roll Forward]
Beginning balance	69
Charges	0
Cash payments	(61)
Non-cash payments	0
Ending balance	$ 8

Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2026	$ 3,348
2027	4,422
2028	4,400
2029	3,653
2030	3,404
Thereafter	5,683
Total net carrying value of intangible assets	$ 24,910	$ 26,027

Acquisitions - Assets Acquired And Liabilities Assumed (Details) - USD ($) $ in Thousands	Mar. 04, 2025	Mar. 31, 2026	Dec. 31, 2025
Business Combination [Line Items]
Goodwill		$ 30,070	$ 30,070
Optical Proximity Correction Suite of Tools (“OPC Business”)
Business Combination [Line Items]
Contract asset	$ 615
Deferred tax asset	164
Goodwill	5,147
Deferred revenue	(416)
Net assets acquired and liabilities assumed	$ 11,500
Optical Proximity Correction Suite of Tools (“OPC Business”) \| Developed technology
Business Combination [Line Items]
Weighted Average Amortization Period (Years)	7 years
Finite-lived intangible assets	$ 1,000
Optical Proximity Correction Suite of Tools (“OPC Business”) \| Customer relationships
Business Combination [Line Items]
Weighted Average Amortization Period (Years)	6 years
Finite-lived intangible assets	$ 4,990

Significant Balance Sheet Components - Prepaid Expense And Other Current Assets And Other Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Prepaid Expense and Other Assets, Current [Abstract]
Research and development tax credits and grants	$ 1,514	$ 1,666
Software and subscriptions	939	1,089
Deferred sales commissions	738	751
Current lease deposits	144	163
Other prepaid expenses	934	1,059
Prepaid expenses and other current assets	$ 4,269	$ 4,728
Amortization period of sales commissions (in years)	5 years

Intangible Assets - Narrative (Details) $ in Millions	Jan. 01, 2026 USD ($)
Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Intangible assets retired	$ 0.8

Sale of Common Stock (Details) - Private Placement - Jefferies LLC - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Mar. 13, 2026	Mar. 31, 2026
Equity, Class of Treasury Stock [Line Items]
Aggregate public offering amount	$ 15.0
Sale of stock, number of shares issued in transaction (in shares)		752,744
Sale of stock, price per share (in dollars per share)		$ 5.75
Sale of stock, consideration received on transaction, including underwriting discounts and commissions		$ 4.3
Gross proceeds, after deducting commissions and other related fees		4.0
Payments of underwriting discounts and commissions		$ 0.3

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Mar. 31, 2025
Income Tax Disclosure [Abstract]
Income tax provision	$ 136	$ 213
Effective income tax rate reconciliation (in percent)	(1.90%)	(1.00%)

Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Financial assets:
Cash equivalents		$ 161
Available-for-sale marketable securities		1,018
Total	$ 3,186	1,179
Liabilities:
Contingent consideration	1,310	1,741
Total	1,310	1,741
U.S. government agencies securities
Financial assets:
Available-for-sale marketable securities		1,018
Money market funds
Financial assets:
Cash equivalents	3,186	161
Level 1
Financial assets:
Cash equivalents		161
Available-for-sale marketable securities		0
Total	3,186	161
Liabilities:
Contingent consideration	0	0
Total	0	0
Level 1 \| U.S. government agencies securities
Financial assets:
Available-for-sale marketable securities		0
Level 1 \| Money market funds
Financial assets:
Cash equivalents	3,186	161
Level 2
Financial assets:
Cash equivalents		0
Available-for-sale marketable securities		1,018
Total	0	1,018
Liabilities:
Contingent consideration	0	0
Total	0	0
Level 2 \| U.S. government agencies securities
Financial assets:
Available-for-sale marketable securities		1,018
Level 2 \| Money market funds
Financial assets:
Cash equivalents	0	0
Level 3
Financial assets:
Cash equivalents		0
Available-for-sale marketable securities		0
Total	0	0
Liabilities:
Contingent consideration	1,310	1,741
Total	1,310	1,741
Level 3 \| U.S. government agencies securities
Financial assets:
Available-for-sale marketable securities		0
Level 3 \| Money market funds
Financial assets:
Cash equivalents	$ 0	$ 0

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2026	May 04, 2026
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2026
Document Transition Report	false
Entity File Number	001-42043
Entity Registrant Name	Silvaco Group, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-1503712
Entity Address, Address Line One	4701 Patrick Henry Drive
Entity Address, Address Line Two	Building #23
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	567-1000
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	SVCO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		32,681,239
Document Fiscal Year Focus	2026
Entity Central Index Key	0001943289
Amendment Flag	false
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31

Debt and Financing Obligations - Schedule of Contractual Obligation, Fiscal Year Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Maturities of Long-Term Debt [Abstract]
Remainder of 2026	$ 1,200
2027	1,200
2028	1,200
Total undiscounted cash flows	3,600
Less: Imputed interest	325
Present value of vendor financing obligation	3,275	$ 3,200
Vendor financing obligation, current	1,191	1,165
Vendor financing obligation, non-current	$ 2,084	$ 2,038

Significant Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued employee expenses	$ 5,364	$ 6,263
Accrued taxes payable	1,634	1,333
Accrued operating expense	1,568	1,525
Contingent consideration	1,310	1,741
Accrued royalties payable	317	285
Litigation settlement	0	8,250
Other	92	0
Total accrued expenses and other current liabilities	$ 10,284	$ 19,397

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2026
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Warranties The Company typically provides its customers a warranty on its software licenses for a period of no more than 90 days and on its other tools for a period of no more than one year. Such warranties are accounted for in accordance with the authoritative guidance issued by the FASB on contingencies. For the three months ended March 31, 2026, and 2025, the Company has not incurred any costs related to warranty obligations. Indemnification Under the terms of substantially all of its license agreements, the Company has agreed to indemnify its customers for costs and damages arising from claims against such customers based on, among other things, allegations that the Company’s software infringes the intellectual property rights of a third party. In most cases, in the event of an infringement claim, the Company retains the right to (i) procure for the customer the right to continue using the software; (ii) replace or modify the software to eliminate the infringement while providing substantially equivalent functionality; or (iii) if neither (i) nor (ii) can be reasonably achieved, the Company may terminate the license agreement and refund to the customer a pro-rata portion of the license fee paid to the Company. Such indemnification provisions are accounted for in accordance with the authoritative guidance issued by the FASB on guarantees. From time to time, in the ordinary course of business, the Company receives claims for indemnification. Contingencies In December 2020, the Company sought declaratory relief in the California Superior Court to clarify its obligations regarding the earnout payments due to the former stockholders of Nangate following its acquisition by the Company in 2018. The Nangate Parties subsequently filed a cross-complaint against the Company and the Co-Defendants seeking $20.0 million in damages for breach of contract, fraud, and unfair business practices, as well as punitive damages. On July 23, 2024, a jury awarded the Nangate Parties $11.3 million in damages under breach of contract related claims, including breach of contract and breach of the covenant of good faith and fair dealing and court and litigation related costs and expenses to be determined by the court (the “Contract Damages”). As a result, during the year ended December 31, 2024, the Company recorded a charge to litigation settlement and accrued expenses and other current liabilities of $11.3 million for the Contract Damages awarded to the Nangate Parties. The jury also found the Company and the Co-Defendants liable for certain of the misrepresentation claims and awarded the Nangate Parties $6.6 million in compensatory damages, for which the Company and the Co-Defendants were joint and severally liable. Incremental punitive damages relating to these claims, including $17.0 million payable by the Company and a total of $16.0 million to be paid by the Co-Defendants, were awarded following a hearing on August 16, 2024 (collectively, the “Fraud Damages”). Under California law, the Nangate Parties were entitled to elect either the Contract Damages or the Fraud Damages but could not receive both. The Company recorded an additional charge to litigation settlement of $13.1 million for the three months ended March 31, 2025. In May 2025, the parties entered into the Settlement Agreement pursuant to which the Company and the Co-Defendants agreed to pay the Nangate Parties an aggregate amount of $32.5 million in full resolution of all claims. In September 2025, the U.S. Court of Appeals for the Ninth Circuit reversed the fraud and breach of contract verdicts following the parties’ joint stipulation, and the parties then dismissed all claims. As of March 31, 2026, there is no remaining liability under the Settlement Agreement. Refer to Note 7, Related Parties, for further information. The Company is party to various litigation matters and claims arising from time-to-time in the ordinary course of business. While the results of such matters cannot be predicted with certainty, unless disclosed above, the Company believes that the final outcome of such matters will not have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows. However, each of these matters is subject to various uncertainties and it is possible that an unfavorable resolution of one or more of these proceedings could materially affect the Company.

Stock-Based Compensation - Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	$ 2,954	$ 2,277
Cost of revenue
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	277	199
Research and development
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	915	244
Selling and marketing
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	442	323
General and administrative
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense	$ 1,320	$ 1,511

Segment Reporting - Narrative (Details)	3 Months Ended
Segment Reporting - Narrative (Details)	Mar. 31, 2026 segment
Segment Reporting [Abstract]
Number of reportable segments	1
Number of operating segments	1

Segment Reporting - Schedule of Reconciliation of Operating Profit (Loss) from Segments to Consolidated (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Segment Reporting, Asset Reconciling Item [Line Items]
Total revenue	$ 17,755	$ 14,092
Net loss	(5,860)	(19,273)
Reportable Segment
Segment Reporting, Asset Reconciling Item [Line Items]
Total revenue	17,755	14,092
Payroll expenses	16,350	14,532
All other expenses, net	7,265	18,833
Total expenses	23,615	33,365
Net loss	$ (5,860)	$ (19,273)

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 10,925	$ 9,008
Restricted cash	0	8,250
Current marketable securities	0	1,018
Accounts receivable, net	9,192	9,710
Contract assets, net	13,781	13,362
Prepaid expenses and other current assets	4,269	4,728
Total current assets	38,167	46,076
Non-current assets:
Property and equipment, net	1,372	1,525
Operating lease right-of-use assets, net	2,017	3,114
Intangible assets, net	24,910	26,027
Goodwill	30,070	30,070
Non-current portion of contract assets	13,324	14,272
Other assets	1,590	1,558
Total non-current assets	73,283	76,566
Total assets	111,450	122,642
Current liabilities:
Accounts payable	3,558	3,483
Accrued expenses and other current liabilities	10,284	19,397
Accrued income taxes	2,071	2,486
Deferred revenue, current	8,824	10,751
Operating lease liabilities, current	1,032	1,121
Vendor financing obligation, current	1,191	1,165
Total current liabilities	26,960	38,403
Non-current liabilities:
Deferred revenue, non-current	4,728	5,157
Operating lease liabilities, non-current	965	1,961
Vendor financing obligation, non-current	2,084	2,038
Other non-current liabilities	0	94
Total liabilities	34,737	47,653
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025	0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 32,234,263 and 30,948,403 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	3	3
Additional paid-in capital	154,007	146,136
Accumulated deficit	(75,078)	(69,218)
Accumulated other comprehensive loss	(2,219)	(1,932)
Total stockholders' equity	76,713	74,989
Total liabilities and stockholders' equity	$ 111,450	$ 122,642

Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2026 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 1,741
Change in fair value	76
Earn-out payments in cash	(43)
Earn-out payments in shares of common stock	(464)
Ending balance	$ 1,310

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenue:
Total revenue	$ 17,755	$ 14,092
Cost of revenue	2,417	3,016
Gross profit	15,338	11,076
Operating expenses:
Research and development	9,159	4,800
Selling and marketing	4,822	4,719
General and administrative	7,014	8,120
Litigation settlement	0	13,069
Total operating expenses	20,995	30,708
Operating loss	(5,657)	(19,632)
Interest income	47	863
Interest and other expense, net	(114)	(291)
Loss before income tax provision	(5,724)	(19,060)
Income tax provision	136	213
Net loss	$ (5,860)	$ (19,273)
Net loss per share:
Basic (in dollars per share)	$ (0.19)	$ (0.67)
Diluted (in dollars per share)	$ (0.19)	$ (0.67)
Weighted average shares used in computing per share amounts:
Basic (in shares)	31,365,903	28,694,295
Diluted (in shares)	31,365,903	28,694,295
Software license revenue
Revenue:
Total revenue	$ 11,609	$ 10,009
Maintenance and service
Revenue:
Total revenue	$ 6,146	$ 4,083

Sale of Common Stock	3 Months Ended
Sale of Common Stock	Mar. 31, 2026
Equity [Abstract]
Sale of Common Stock	Sale of Common Stock On March 13, 2026, the Company entered into an Open Market Sale Agreement with Jefferies LLC, as sales agent, pursuant to which the Company may conduct registered offers and sales of shares of the Company’s common stock under the Company’s registration statement on Form S-3 (Registration No. 333-291212) and a prospectus supplement dated March 13, 2026, for an aggregate public offering amount of up to $15.0 million. During the three months ended March 31, 2026, the Company issued 752,744 shares of common stock at a weighted average price of $5.75 per share. The Company received gross proceeds of $4.3 million, with $4.0 million funded to the Company after deducting commissions and other related fees of $0.3 million. The commissions and related fees were recorded as a reduction to additional paid-in capital.

Acquisitions - Narrative (Details) - USD ($) $ in Thousands			1 Months Ended	3 Months Ended
Acquisitions - Narrative (Details) - USD ($) $ in Thousands	Apr. 29, 2025	Mar. 04, 2025	Feb. 28, 2026	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Business Combination [Line Items]
Cash payments to acquire business				$ 0	$ 11,500
Contingent consideration				1,310		$ 1,741
Optical Proximity Correction Suite of Tools (“OPC Business”)
Business Combination [Line Items]
Cash payments to acquire business		$ 11,500
Acquisition-related expenses				$ 0	$ 700
Tech-X Corporation (“Tech-X”)
Business Combination [Line Items]
Cash payments to acquire business	$ 4,100
Purchase price	$ 8,200
Shares issued in business combination (in shares)	457,666		167,281
Shares issued in business combination, fair value	$ 2,400
Maximum contingent consideration payout	2,000
Contingent consideration	$ 1,700
Issuance of common stock to settle contingent consideration			$ 700

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (5,860)	$ (19,273)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,273	438
Stock-based compensation expense	2,954	2,277
Provision for estimated credit losses	132	10
Litigation settlement	0	13,069
Accretion of discount on marketable securities, net	15	(261)
Change in fair value of contingent consideration	76	35
Changes in operating assets and liabilities:
Accounts receivable	490	3,520
Contract assets	120	440
Prepaid expenses and other current assets	244	(1,026)
Other assets	(41)	119
Accounts payable	69	(1,183)
Accrued expenses and other current liabilities	(7,889)	55
Accrued income taxes	(415)	58
Deferred revenue	(2,142)	567
Other non-current liabilities	(48)	20
Net cash used in operating activities	(11,022)	(1,135)
Cash flows from investing activities:
Maturities of marketable securities	1,000	23,000
Acquisition of businesses	0	(11,500)
Purchases of property and equipment	0	(96)
Net cash provided by investing activities	1,000	11,404
Cash flows from financing activities:
Net proceeds from issuance of common stock	3,992	0
Payments of contingent consideration	(43)	(46)
Payment of payroll taxes related to shares withheld from employees	(261)	(252)
Payments of vendor financing obligation	0	(205)
Net cash provided by (used in) financing activities	3,688	(503)
Effect of exchange rate fluctuations on cash and cash equivalents	1	117
Net (decrease) increase in cash, cash equivalents and restricted cash	(6,333)	9,883
Cash, cash equivalents, and restricted cash beginning of period	17,258	19,606
Cash and cash equivalents, end of period	$ 10,925	$ 29,489

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024		28,526,615
Beginning balance at Dec. 31, 2024	$ 100,083	$ 3	$ 130,360	$ (28,012)	$ (2,268)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for share-based award plans (in shares)		332,444
Tax withholding on restricted stock unit settlements (in shares)		(53,779)
Tax withholding on restricted stock unit settlements	(253)		(253)
Stock-based compensation expense	2,830		2,830
Other comprehensive (loss) income	206				206
Net loss	(19,273)			(19,273)
Ending balance (in shares) at Mar. 31, 2025		28,805,280
Ending balance at Mar. 31, 2025	$ 83,593	$ 3	132,937	(47,285)	(2,062)
Beginning balance (in shares) at Dec. 31, 2025	30,948,403	30,948,403
Beginning balance at Dec. 31, 2025	$ 74,989	$ 3	146,136	(69,218)	(1,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with the open market sale agreement, net of commissions and related fees (in shares)		752,744
Issuance of common stock in connection with the open market sale agreement, net of commissions and related fees	3,992		3,992
Issuance of common stock to settle obligations due to Tech-X shareholder (in shares)		167,281
Issuance of common stock to settle obligations due to Tech-X shareholder	565		565
Issuance of common stock for share-based award plans (in shares)		436,089
Tax withholding on restricted stock unit settlements (in shares)		(70,254)
Tax withholding on restricted stock unit settlements	(261)		(261)
Stock-based compensation expense	3,575		3,575
Other comprehensive (loss) income	(287)				(287)
Net loss	$ (5,860)			(5,860)
Ending balance (in shares) at Mar. 31, 2026	32,234,263	32,234,263
Ending balance at Mar. 31, 2026	$ 76,713	$ 3	$ 154,007	$ (75,078)	$ (2,219)

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2026	Dec. 31, 2025
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	500,000,000	500,000,000
Common stock, issued (in shares)	32,234,263	30,948,403
Common stock, outstanding (in shares)	32,234,263	30,948,403

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2026
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes During the three months ended March 31, 2026, and March 31, 2025, the Company recorded an Income tax provision of $0.1 million and $0.2 million, respectively. The effective tax rate for the three months ended March 31, 2026, and 2025 was (1.9)% and (1)%, respectively. The Company determines its income tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items occurring during the periods presented. The difference between its effective tax rate and the federal statutory rate is primarily attributable to state income taxes, foreign income taxes, the effect of certain permanent differences, and full valuation allowance against net deferred tax assets. The Company files income tax returns in the U.S. federal jurisdiction, various state jurisdictions and certain foreign jurisdictions. The Company is currently under audit by the Internal Revenue Service for its 2022 return, but no assessments have been issued. There are no audits currently underway for state, local, and foreign authorities. All tax years remain open to examination by major taxing jurisdictions to which the Company is subject for a period of 3 years for federal and 4 years for states, after the utilization of net operating losses and credits.